LearnGlossaryMarketStocksSuperinvestorsSign in

DRTS

Alpha Tau Medical Ltd

Healthcare · $1.3B market cap

Verdict

We can't put a fair value on DRTS right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth-21.8% a year✗
Sales growth—?
Free cash flow growth—?
Return on invested capital-41.5%✗

Follow DRTS

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds DRTS. In Q2 2026, 1 opened a position. Who we track

Polen Capital Management

Polen Capital Management · as of Q2 2026

$2.8M

220,751 shares

Moves in Q2 2026

New position: Polen Capital Management

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors…

Biotechnology

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works